Osoria ML, Castro MAF, Hidalgo TO, Martínez CR, Acosta CJ

Language: Spanish
References: 25
Page: 288-297
PDF size: 423.96 Kb.

ABSTRACT

Introduction: Cardiovascular disease is a significant comorbidity and, simultaneously, the leading cause of death in patients with chronic kidney disease.
Objective: To describe the association between risk factors and cardiovascular disease in patients on a continuous hemodialysis plan.
Method: A descriptive, longitudinal and retrospective study was conducted in 49 patients who participated in a continuous hemodialysis plan at the Calixto García Hospital in 2012. Odds ratio was used for the association between variables, with its confidence interval and Fisher's exact test.
Results: 83.7% of patients were hypertensive and 71.4% showed left ventricular hypertrophy. Old age was the risk factor most consistently associated with such hypertrophy [OR=4.35 (CI=1.03 to 18.37); p = 0.036]. The risk factors that were associated with diastolic dysfunction included hypertension [OR=9.88 (CI=1.11 to 87.90); p=0.021], diabetes mellitus [OR=12.94 (CI=1.49 to 112.44); p=0.006], and hypoalbuminemia [OR=4.67 (CI=1.09 to 19.90); p=0.030]. No risk factor was associated with mitral valve disease.
Conclusions: The most prevalent health condition was hypertension, and most of the population had left ventricular hypertrophy, which was associated with old age; just as hypertension, diabetes mellitus, and hypoalbuminemia were associated with diastolic dysfunction. No statistical association between mitral valve disease and any of the analyzed risk factors was found.

REFERENCES

1. Marín R. Riñón y enfermedad cardiovascular. Ne-frologia. 2004;24(Supl 6):17-20.

2. Ministerio de Salud Pública. Anuario Estadístico de Salud 2011. La Habana: Dirección Nacional de Registros Médicos y Estadísticas; 2012.

3. Wright J, Hutchison A. Cardiovascular disease in patients with chronic kidney disease. Vasc Health Risk Manag. 2009;5:713-22.

4. Rodríguez R, Cueto E, Casamayor Z, Martínez M, Barroso J, González O. Prevalencia de factores de riesgo cardiovascular en pacientes con enfermedad renal crónica. Rev Cub Med Mil [Internet]. 2010 [ci-tado 15 Sep 2013];39(1):[aprox. 4p.]. Disponible en: http://scielo.sld.cu/scielo.php?pid=S0138-65572010000100004&script=sci_arttext

5. Johnson DW. Prevention of progression of kidney diseases – CARI guidelines. Aust Fam Physician. 2007;36(5):353.

6. Landray M, Thambyrajah J, McGlynn F, Jones H, Baigent C, Kendall M, et al. Epidemiological eva-luation of known and suspected cardiovascular risk factors in chronic renal impairment. Am J Kidney Dis. 2001;38(3):537-46.

7. Ventura JE. Riesgo cardiovascular en pacientes con enfermedad renal crónica. Rev Urug Cardiol. 2006; 21(2):143-57.

8. Bardají A, Martínez-Vea A. Enfermedad renal cróni-ca y corazón. Un continuo evolutivo. Rev Esp Car-diol. 2008;61(Supl 2):41-51.

9. Rodríguez JL, Batista O. Comportamiento de morta-lidad en el servicio de nefrología. Años 2009-2010. Las Tunas. Rev Electron Biomed [Internet]. 2011 [citado 23 May 2014];3:24-33. Disponible en: http://biomed.uninet.edu/2011/n3/rodriguez.html

10. 10.Grigorian L, Varela A, Pedreira M, Gómez I, Virgos A, González-Juanatey JR. La insuficiencia renal es un predictor independiente de la mortalidad en pa-cientes hospitalizados por insuficiencia cardíaca y se asocia con un peor perfil de riesgo cardiovascu-lar. Rev Esp Cardiol. 2006;59(2):99-108.

11. 11.Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of Chronic Kidney Dis-ease in the United States. J Am Med Assoc. 2007; 298(17):2038-47. 12.Garimella PS, Uhlig K. Current issues in the manage-ment and monitoring of hypertension in chronic kidney disease. Curr Opin Nephrol Hypertens. 2013; 22(6):599-606. 13.Díaz Gómez JL, Landell Cruz J, Lazo Sánchez Y, Argo-te Viñals C. Comportamiento de la insuficiencia renal crónica terminal en el Servicio de Nefrología de las Tunas. Rev Electrón Dr. Zoilo E. Marinello Vidaurreta [Internet]. 2005 [citado 12 May 2014];29(May-Ago):[aprox. 6 p.]. Disponible en: http://www.ltu.sld.cu/revistam/index_files/articles/mayo-agosto2005_5.htm

12. 14.Zamora E, Lupón J, Vila J, Urrutia A, de Antonio M, Sanz H, et al. Estimated glomerular filtration rate and prognosis in heart failure: value of the Modi-fication of Diet in Renal Disease Study-4, chronic Kidney disease epidemiology collaboration, and cockroft-gault formulas. J Am Coll Cardiol. 2012; 59(19):1709-15.

13. 15.Kalaitzidis RG, Brakis G. Serum Creatinine vs. al-buminuria as biomarkers for the estimation of cardiovascular risk. Curr Vasc Pharmacol. 2010,8(5): 604-11. 16.Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease. Effects on the cardiovascular system. Cir-culation. 2007;116(1):85-97.

14. 17.Marín R, Goicoechea MA, Gorostidi M, Cases A, Díez J, Escolar G, et al. Guía de la Sociedad Española de Nefrología sobre riñón y enfermedad cardiovas-cular. Versión abreviada. Nefrologia. 2006;26(1):31-44.

15. 18.Eckardt K, Scherhag A, Macdougall I, Naomi D, Lo-catelli F, Zaug M, et al. Left ventricular geometry predicts cardiovascular outcomes associated with anemia correction in CKD. J Am Soc Nephrol. 2009; 20(12):2651-60.

16. 19.González I, Casanova C, Escobar C, García A, Peraira JR, Prieto E, et al. Enfermedad Cardiovascular y función renal. Mecanismos patogénicos. Rev Esp Cardiol. 2008;8(Supl E):10-21.

17. 20.van der Zee S, Baber U, Elmariah S, Winston J, Fus-ter V. Cardiovascular risk factors in patients with chronic kidney disease. Nat Rev Cardiol. 2009;6(9): 580–9. 21.Rodríguez L, Arencibia FL, Serrano A, de la Cruz S. Factores de riesgo y complicaciones cardiovascu-lares en pacientes con diálisis peritoneal. Rev Cub Medic Intens Emerg [Internet]. 2004 [citado 12 Sep 2013];4(1):[aprox. 3 p.]. Disponible en: http://www.bvs.sld.cu/revistas/mie/vol4_1_05/mie03105.htm

18. 22.Masugata H, Senda Sh, Goda F, Yamagami A, Oku-yama H, Kohno T, et al. Echocardiographic assess-ment of the cardio-renal connection: is left ventri-cular hypertrophy or diastolic function more closely correlated with estimated glomerular filtration rate in patients with cardiovascular risk factors? Clin Exp Hypertens. 2010;32(2):113-20.

19. 23.Muntner P, He J, Astor BC, Folsom AR, Coresh J. Traditional and nontraditional risk factors predict coronary heart disease in chronic Kidney disease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol. 2005;16(2): 529-38.

20. 24.Barberato SH, Bucharle SG, Sousa AM, Costantinin CO, Costantino R, Pecoits-Filho R. Prevalência e impacto prognóstico da disfunção diastólica na doença renal crônica em hemodiálise. Arq Bras Cardiol. 2010;94(4):457-62.

21. 25.Shah DS, Polkinghorne KR, Pellicano R, kerr PG. Are traditional risk factors valid for assessing cardiovas-cular risk in end-stage renal failure patients? Ne-phrology. 2008;13(8):667-71.

22. 26.Collado S, Coll E, Guerrero DL, Pons M, Cruzado JM, Vera M, et al. Prevalencia de enfermedad cardio-vascular en la uremia y relevancia de los factores de riesgo cardiovascular. Nefrologia. 2010;30(3): 342-8.

23. 27.Longo D, Kasper D, Jameson J, Fauci A, Hauser S, Loscalzo J. Harrison's Principles of Internal Medi-cine. 18 ed. New York: McGraw-Hill, 2012.

24. 28.Leskinen Y, Paana T, Saha H, Groundstroem K, Leh-timäki T, Kilpinen S, et al. Valvular calcification and its relationship to atherosclerosis in chronic kidney disease. J Heart Valve Dis. 2009;18(4):429-38.

25. 29.Rao AK, Djamali A, Korcarz CE, Aeschlimann SE, Wolff MR, Stein JH. Mitral annular calcification is associated with reduced left ventricular function and inflammation in patients with chronic kidney disease. J Am Soc Echocardiogr. 2008;21(6):747-50.